Loading asset research
Pliant Therapeutics Inc. Common Stock
PLRXNasdaq · USD · StocksQuote as of · Exchange session not verified$1.17
+3.54%
Today
PLRX
Loading 1D prices…
Market cap
$72.4M
Volume
173.5K
52w high
$1.9552w low
$1.02Company profile
Pliant Therapeutics Inc. Common Stock
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
South San Francisco, CA, United States
Employees
49
Fiscal year end
1231
CIK
1746473
Session & valuation
Open$1.14
Previous close$1.13
Day high$1.18
Day low$1.14
30-day avg. volume417.1K
Outstanding shares61.9M
Diluted EPS-$2.43
Latest annual period
P/E (trailing)-0.48
P/E (forward)-0.91
Price / book0.49
Beta1.28
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| YARWYarrow Bioscience Inc. Common Stock | $72.1M | $570K | -4646.14% | -$0.62 | -5.03% | Hold |
| CINGCingulate Inc. Common Stock | $73M | $0.00 | — | -$4.44 | -2.51% | Buy |
| ZYBTZhengye Biotechnology Holding Limited Class A Ordinary Shares | $73.5M | $16.6M | -59.99% | $0.25 | -2.52% | Unrated |
| ATHEAlterity Therapeutics Limited American Depositary Shares | $73.7M | — | — | -$1.33 | -1.22% | Buy |
| PMVPPMV Pharmaceuticals Inc. Common Stock | $74.8M | $0.00 | — | -$1.48 | -1.39% | Buy |